Approach to intraoperative consultation for donor liver biopsies

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 2, 2013, Pages 270-274

  Melin, Claire ^a   Miick, Ronald ^b   Young, Nancy A ^b   Ortiz, Jorge ^b   Balasubramanian, Manjula ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; DONOR; DONOR SELECTION; DRUG CONTRAINDICATION; FATTY LIVER; FROZEN SECTION; HEPATITIS C; HUMAN; INTRAOPERATIVE PERIOD; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVER TUMOR; LIVING DONOR; NECROSIS; NODULAR HYPERPLASIA; PATHOLOGY; PATIENT REFERRAL; REVIEW; RISK FACTOR; SIDEROSIS; TRANSPLANTATION;

BIOPSY; DONOR SELECTION; FATTY LIVER; FOCAL NODULAR HYPERPLASIA; FROZEN SECTIONS; HEPATITIS C, CHRONIC; HUMANS; INTRAOPERATIVE PERIOD; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; NECROSIS; PATHOLOGY, SURGICAL; REFERRAL AND CONSULTATION; RISK FACTORS; SIDEROSIS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS;

EID: 84874676753     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0689-RA     Document Type: Review

References (45)

1. Organ Procurement and Transplantation Network Web site. http://optn. transplant.hrsa.gov. Accessed March 15, 2012.
2. D'Alessandro AM, Hoffmann RM, Knechtle SJ, et al. Liver transplantation from controlled non-heart-beating donors. Surgery. 2000;128(4): 579-588.
3. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl. 2003;9(7): 651-663.
4. Liver. Transplant Pathology Internet Services Web site. http://tpis.upmc. com/TPIShome/changeBody.jsp?url=/tpis/liver/LDonorFS.jsp?. Updated June 18, 2009. Accessed March 15, 2012.
5. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept ofadonor risk index. Am J Transplant. 2006; 6(4): 783-790.
6. Gastaca M. Extended criteria donors in liver transplantation: adapting donor quality and recipient. Transplant Proc. 2009;41(3): 975-979.
7. Grande L, Rull A, Rimola A, et al. Outcome of patients undergoing orthotopic liver transplantation with elderly donors (over 60 years). Transplant Proc. 1997;29(8): 3289-3290.
8. Broughan TA, Douzdjian V. Donor liver selection: the South-Eastern Organ Procurement Foundation Liver Committee. Am Surg. 1998;64(8): 785-790.
9. Makowka L, Gordon RD, Todo S, et al. Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc. 1987; 19(1)(pt 3): 2378-2382.
10. Todo S, Demetris AJ, Makowka L, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation. 1989;47(5): 903-905.
11. D'Alessandro AM, Kalayoglu M, Sollinger HW, et al. The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc. 1991;23(1)(pt 2): 1536-1537.
12. Loinaz C, Gonzalez EM. Marginal donors in liver transplantation. Hepatogastroenterology. 2000;47(31): 256-263.
13. Ureña MA, Ruiz-Delgado FC, Gonzalez EM, et al. Assessing risk of the use of livers with macro and microsteatosis inaliver transplant program. Transplant Proc. 1998;30(7): 3288-3291.
14. Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation. 1997;64(2): 248-251.
15. Imber CJ, St Peter SD, Lopez I, Guiver L, Friend PJ. Current practice regarding the use of fatty livers: a trans-Atlantic survey. Liver Transpl. 2002;8(6): 545-549.
16. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation. 1993;55(4): 807-813.
17. Kakizoe S, Yanaga K, Starzl TE, Demetris AJ. Frozen section of liver biopsy for the evaluation of liver allografts. Transplant Proc. 1990;22(2): 416-417.
18. Markin RS, Wisecarver JL, Radio SJ, et al. Frozen section evaluation of donor livers before transplantation. Transplantation. 1993;56(6): 1403-1409.
19. Adam R, Reynes M, Johann M, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc. 1991;23(1)(pt 2): 1538-1540.
20. Araya QA, Valera MJ, Contreras BJ, et al. Glucose tolerance alterations and frequency of metabolic syndrome among patients with non alcoholic fatty liver disease [in Spanish]. Rev Med Chil. 2006;134(9): 1092-1098.
21. Brookes MJ, Cooper BT. Hypertension and fatty liver: guilty by association? J Hum Hypertens. 2007;21(4): 264-270.
22. Saadeh S. Nonalcoholic fatty liver disease and obesity. Nutr Clin Pract. 2007;22(1): 1-10.
23. Conde Martel A, González Reimers E, Santolaria Fernández F, Castro Aleman V, Marchena Gomez J, Martinez Riera A. Liver changes in protein malnutrition: an experimental study in rats [in Spanish]. Nutr Hosp. 1993;8(6): 358-363.
24. Crawford JM, Liu C. Liver and biliary tract. In: Kumar V, Abbas AK, Fausto N, Aster J, eds. Robbins and Cotran Pathologic Basis of Disease. 8th ed. Philadelphia, PA: Saunders; 2010: 833-890.
25. Adam R, Sanchez C, Astarcioglu I, Bismuth H. Deleterious effect of extended cold ischemia time on the posttransplant outcome of aged livers. Transplant Proc. 1995;27(1): 1181-1183.
26. Takeda Y, Arii S, Kaido T, et al. Morphologic alteration of hepatocytes and sinusoidal endothelial cells in rat fatty liver during cold preservation and the protective effect of hepatocyte growth factor. Transplantation. 1999;67(6): 820-828.
27. Findor J, Perez V, Igartua EB, Giovanetti M, Fioravantti N. Structure and ultrastructure of the liver in aged persons. Acta Hepatogastroenterol (Stuttg). 1973;20(3): 200-204.
28. Ferrell L, Bass N, Roberts J, Ascher N. Lipopeliosis: fat induced sinusoidal dilatation in transplanted liver mimicking peliosis hepatis. J Clin Pathol. 1992; 45(12): 1109-1110.
29. Adam R, Bismuth H, Diamond T, et al. Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet. 1992; 340(8832): 1373-1376.
30. Fiorentino M, Vasuri F, Ravaioli M, et al. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Liver Transpl. 2009;15(12): 1821-1825.
31. Hübscher SG, Portmann BC. Transplantation pathology. In: Burt AD, Portmann BC, Ferrell LD, eds. MacSween's Pathology of the Liver. 5th ed. Philadelphia, PA: Elsevier/Churchill Livingstone; 2007: 815-879.
32. Marsman H, Matsushita T, Dierkhising R, et al. Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol. 2004;35(4): 430-435.
33. Vargas HE, Laskus T, Wang LF, et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology. 1999;117(1): 149-153.
34. Testa G, Goldstein RM, Netto G, et al. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation. 1998; 65(7): 925-929.
35. Velidedeoglu E, Desai NM, Campos L, et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation. 2002;73(4): 582-587.
36. Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation. 1999;68(7): 1058-1061.
37. Dickson RC, Everhart JE, Lake JR, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen: the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology. 1997;113(5): 1668-1674.
38. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995;19: 1409-1417.
39. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22: 696-699.
40. Demetris AJ, Crawford JM, Minervini M, et al. Transplantation pathology of the liver. In: Odze RD, Goldblum JR, eds. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. 2nd ed. Philadelphia, PA: Saunders/Elsevier; 2009: 1169-1229.
41. Abraham S, Furth EE. Quantitative evaluation of histological features in ''time-zero'' liver allograft biopsies as predictors of rejection or graft failure: receiver-operating characteristic analysis application. Hum Pathol. 1996;27(10): 1077-1084.
42. Detry O. Liver graft procurement in donors with central nervous system cancers. Liver Transpl. 2010;16(7): 914-915.
43. Doyle MB, Vachharajani N, Wellen JR, et al. Short- and long-term outcomes after steatotic liver transplantation. Arch Surg. 2010;145(7): 653-660.
44. Portmann BC, Thompson RJ, Roberts EA, Paterson AC. Genetic and metabolic liver disease. In: Burt AD, Portmann BC, Ferrell LD, eds. MacSween's Pathology of the Liver. 5th ed. Philadelphia, PA: Elsevier/Churchill Livingstone; 2007: 199-326.
45. Singh N, Sun HY. Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens. Liver Transpl. 2008;14(9): 1249-1255.